Immunogenicity, safety and tolerability of vaccinations in premature infants

Susanna Esposito1, Monica Fumagalli, Nicola Principi

  • 1Pediatric Clinic 1, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. susanna.esposito@unimi.it

Expert Review of Vaccines
|November 27, 2012
PubMed

Insights

Premature infants (PIs) have developing immune systems, making them vulnerable to infections. PIs should follow standard infant vaccination schedules, regardless of birth weight or prematurity, for optimal protection.

Area of Science:

  • Pediatrics
  • Immunology
  • Vaccinology

Background:

  • Neonates and young children exhibit functionally impaired immune defenses, leading to increased susceptibility and severity of infections.
  • Premature infants (PIs) possess a more compromised immune system compared to full-term infants, increasing their risk of serious infectious complications.
  • The severity of infectious issues in PIs correlates with the degree of prematurity.

Purpose of the Study:

  • To review the characteristics of the developing immune system in early life.
  • To analyze the impact of immune impairments on immunization efficacy in PIs.
  • To evaluate the response, safety, and tolerability of vaccines in PIs.

Main Methods:

  • Comprehensive literature review analyzing existing data on infant immunity and vaccination.
  • Assessment of studies focusing on the immune response of premature infants to various vaccines.
  • Evaluation of vaccine safety and tolerability profiles in the premature infant population.

Main Results:

  • Data suggest that premature infants (PIs) can adhere to the standard vaccination schedule recommended for full-term infants.
  • Vaccination schedules for PIs should not be adjusted for prematurity or birth weight.
  • Current evidence supports the safety and tolerability of established vaccines in PIs.

Conclusions:

  • Premature infants (PIs) should receive vaccinations according to the standard schedule without prematurity correction.
  • Further research is essential to assess the efficacy and safety of newly approved and upcoming vaccines in PIs.
  • Consistent vaccination practices are crucial for protecting PIs against preventable infectious diseases.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Vaccinations01:51

Vaccinations

Overview
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.